These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18989232)

  • 1. CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.
    Moore DM; Awor A; Downing R; Kaplan J; Montaner JS; Hancock J; Were W; Mermin J
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):477-84. PubMed ID: 18989232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention.
    Kranzer K; Lawn SD; Johnson LF; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2013 Aug; 63(4):498-505. PubMed ID: 23572010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
    BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.
    Evans DH; Fox MP; Maskew M; McNamara L; MacPhail P; Mathews C; Sanne I
    J Int AIDS Soc; 2014; 17(1):19139. PubMed ID: 25227265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
    Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
    BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.
    Rawizza HE; Chaplin B; Meloni ST; Eisen G; Rao T; Sankalé JL; Dieng-Sarr A; Agbaji O; Onwujekwe DI; Gashau W; Nkado R; Ekong E; Okonkwo P; Murphy RL; Kanki PJ;
    Clin Infect Dis; 2011 Dec; 53(12):1283-90. PubMed ID: 22080121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
    Moore DM; Harris R; Lima V; Hogg B; May M; Yip B; Justice A; Mocroft A; Reiss P; Lampe F; Chêne G; Costagliola D; Elzi L; Mugavero MJ; Monforte AD; Sabin C; Podzamczer D; Fätkenheuer G; Staszewski S; Gill J; Sterne JA;
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):357-63. PubMed ID: 19668084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
    Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
    Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
    Bisson GP; Gross R; Bellamy S; Chittams J; Hislop M; Regensberg L; Frank I; Maartens G; Nachega JB
    PLoS Med; 2008 May; 5(5):e109. PubMed ID: 18494555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda.
    Castelnuovo B; Kiragga A; Mubiru F; Kambugu A; Kamya M; Reynolds SJ
    J Int AIDS Soc; 2016; 19(1):20773. PubMed ID: 27319742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.
    Badri M; Lawn SD; Wood R
    BMC Infect Dis; 2008 Jul; 8():89. PubMed ID: 18601727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
    Kiweewa F; Esber A; Musingye E; Reed D; Crowell TA; Cham F; Semwogerere M; Namagembe R; Nambuya A; Kafeero C; Tindikahwa A; Eller LA; Millard M; Gelderblom HC; Keshinro B; Adamu Y; Maswai J; Owuoth J; Sing'oei VC; Maganga L; Bahemana E; Khamadi S; Robb ML; Ake JA; Polyak CS; Kibuuka H
    PLoS One; 2019; 14(2):e0211344. PubMed ID: 30721233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP; Lawrence J; Reingold AL; Tulsky JP
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.
    Okoboi S; Ekwaru PJ; Campbell JD; Egessa A; King R; Bakanda C; Muramuzi E; Kaharuza F; Malamba S; Moore DM
    BMC Public Health; 2016 Feb; 16():101. PubMed ID: 26830678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is CD4 monitoring needed among ugandan clients achieving a virologic and immunologic response to treatment?
    Reynolds SJ; Sempa JB; Kiragga AN; Newell K; Nakigozi G; Galiwango R; Gray R; Quinn TC; Serwadda D; Chang L
    AIDS Patient Care STDS; 2014 Nov; 28(11):575-8. PubMed ID: 25290988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Early Virological Response in HIV-Infected Individuals Starting Antiretroviral Therapy in Brazil (2014-2015): Results From a Large HIV Surveillance Cohort.
    Meireles MV; Pascom ARP; Duarte EC
    J Acquir Immune Defic Syndr; 2018 Aug; 78(4):e19-e27. PubMed ID: 29557856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure.
    Rutherford GW; Anglemyer A; Easterbrook PJ; Horvath T; Vitoria M; Penazzato M; Doherty MC
    AIDS; 2014 Mar; 28 Suppl 2():S161-9. PubMed ID: 24849476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.